Acceleron Pharma
XLRN
#1586
Rank
NZ$18.28 B
Marketcap
$299.03
Share price
0.00%
Change (1 day)
14,818.59%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$18.28 Billion

As of November 2024 Acceleron Pharma has a market cap of NZ$18.28 Billion. This makes Acceleron Pharma the world's 1586th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$292.50 B 1,499.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$152.29 B 732.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$626.18 B 3,324.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$34.97 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.99 B-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.13 B-99.28%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$253.31 B 1,285.18%๐Ÿ‡บ๐Ÿ‡ธ USA